Simplify Logo

Full-Time

Vice President/Senior Vice President

Quality

Posted on 5/1/2024

Editas Medicine

Editas Medicine

201-500 employees

Develops CRISPR-based gene editing therapies

Hardware
Biotechnology
Healthcare

Senior

Cambridge, MA, USA

Category
Bioinformatics
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Google Cloud Platform
Requirements
  • Bachelor’s degree required
  • 20 or more years of cGxP experience preferred
  • Experience with cell and/or gene therapy products
  • Strong knowledge in analytical methodologies and technologies
  • Strong knowledge of global regulations and guidelines (EU, U.S., Japan)
  • Previous experience with clinical and commercial manufacturing
  • Experience with BLA/MAA filings and subsequent inspections
  • Proven ability to work independently and in a team-oriented environment
Responsibilities
  • Drive the strategic development and execution of GxP Quality Management System
  • Promote a culture of quality and continuous improvements
  • Lead GxP teams across multiple sites
  • Ensure company-wide adherence to GMP, GCP, GTP, GLP, GDP regulations
  • Provide strong leadership in troubleshooting and complex problem solving
  • Interact professionally with company management and third parties
  • Own the Quality Risk Management, Quality Council, and Management Review programs
  • Ensure a constant state of Inspection Readiness
  • Manage budget and resources in alignment with program timelines
  • Author and review regulatory filings (e.g., IND, IMPD, BLA, MAA)

Editas Medicine is a leader in the biotechnology industry, focused on developing cutting-edge CRISPR gene editing technologies to create transformative medicines for serious diseases. This focus places the company at the forefront of genetic research and therapy development, providing a dynamic and pioneering environment for its employees. As a workplace, it promises a culture of constant learning and innovation, ideal for those passionate about advancing healthcare and contributing to vital medical breakthroughs.

Company Stage

IPO

Total Funding

$884.6M

Headquarters

Cambridge, Massachusetts

Founded

2013

Growth & Insights
Headcount

6 month growth

19%

1 year growth

24%

2 year growth

13%
INACTIVE